KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements. (2021)

First Author: Au YZ
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-020-1001-z

PubMed Identifier: 32764680

Publication URI: http://europepmc.org/abstract/MED/32764680

Type: Journal Article/Review

Volume: 35

Parent Publication: Leukemia

Issue: 4

ISSN: 0887-6924